Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
    19.
    发明授权
    Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists 失效
    吡咯烷基和吡咯啉基乙胺化合物作为κ激动剂

    公开(公告)号:US06310061B2

    公开(公告)日:2001-10-30

    申请号:US09770515

    申请日:2001-01-26

    IPC分类号: A61K31445

    摘要: A compound of the following formula: and the salts thereof, wherein A is hydrogen, halo, or hydroxy; the broken line represents an optional double bond with proviso that if the broken line is a double bond, then A is absent; Ar1 is optionally substituted phenyl; Ar2 is aryl or heteroaryl selected from phenyl, napththyl, or pyridyl, the aryl or heteroaryl being optionally substituted; R1 is hydrogen, hydroxy, or C1-C4 alkyl; and R2 and R3 are independently selected from optionally substituted C1-C7 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, or R2 and R3, together with the nitrogen atom to which they are attached, form an optionally substituted pyrrolidine, piperidine or morpholine ring. These compounds are useful as kappa agonists.

    摘要翻译: 下式的化合物及其盐,其中A是氢,卤素或羟基; 虚线表示任选的双键,条件是如果虚线是双键,则A不存在; Ar1是任选取代的苯基; Ar2是选自苯基,萘乙基或吡啶基的芳基或杂芳基,芳基或杂芳基任选被取代; R1是氢,羟基或C1-C4烷基; 并且R 2和R 3独立地选自任选取代的C 1 -C 7烷基,C 3 -C 6环烷基,C 2 -C 6烯基,C 2 -C 6炔基或R 2和R 3与它们所连接的氮原子一起形成任选取代的 吡咯烷,哌啶或吗啉环。 这些化合物可用作κ激动剂。

    Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists

    公开(公告)号:US06307061B2

    公开(公告)日:2001-10-23

    申请号:US09771029

    申请日:2001-01-26

    IPC分类号: C07D20704

    摘要: A compound of the following formula: and the salts thereof, wherein A is hydrogen, halo, hydroxy, or the like; the broken line represents an optional double bond with proviso that if the broken line is a double bond, then A is absent; Ar1 is optionally substituted phenyl or the like; Ar2 is aryl or heteroaryl selected from phenyl, napththyl, pyridyl, and the like, the aryl or heteroaryl being optionally substituted; R1 is hydrogen, hydroxy, C1-C4 alkyl, or the like; and R2 and R3 are independently selected from optionally substituted C1-C7 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, and the like or R2 and R3, together with the nitrogen atom to which they are attached, form an optionally substituted pyrrolidine, piperidine or morpholine ring. These compounds are useful as kappa agonists.